January 29, 2018
by Kit

Written by Angela Kelly Da Volterra Announces Results from Clinical Trial DAV132 Da Volterra, a French biopharmaceutical company, has announced the stunning results from the clinical study of DAV132. DAV132 was shown in a study of 44 healthy volunteers to protect the native gut flora, while taken in conjunction with …